PT  - JOURNAL ARTICLE
AU  - Said M. Al-Asfar
AU  - Mohammad Attar
AU  - Hasan Shacfeh
TI  - Infliximab treatment for resistant Achilles tendonitis
DP  - 2009 Sep 01
TA  - Saudi Medical Journal
PG  - 1228--1230
VI  - 30
IP  - 9
4099  - http://smj.org.sa/content/30/9/1228.short
4100  - http://smj.org.sa/content/30/9/1228.full
SO  - Saudi Med J2009 Sep 01; 30
AB  - Undifferentiated spondyloarthropathies USPA can sometimes be refractory to usual disease modifying agents. Anti-tumor necrosis factor TNF-alpha agents have been shown to be effective in spondyloarthropathies. Few articles described the efficacy of TNF-alpha antagonists in USPA. Our patient had refractory Achilles tendonitis as an early manifestation of USPA which responded dramatically to infliximab treatment.